Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

Volume: 29, Issue: 6, Pages: 647 - 660
Published: Jun 22, 2021
Abstract
Chimeric antigen receptor (CAR) T-cell therapy is an encouraging and fast-growing platform used for the treatment of various types of tumors in human body. Despite the recent success of CAR T-cell therapy in hematologic malignancies, especially in B-cell lymphoma and acute lymphoblastic leukemia, the application of this treatment approach in solid tumors faced several obstacles resulted from the heterogeneous expression of antigens as well as...
Paper Details
Title
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
Published Date
Jun 22, 2021
Volume
29
Issue
6
Pages
647 - 660
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.